News-Medical.Net on MSN
DLL3 on circulating tumor cells predicts tarlatamab success in lung cancer
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune ...
A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...
Large cell carcinoma is aggressive, requiring early detection through imaging and biopsy for optimal treatment outcomes.
The study, published in British scientific journal Nature, suggests that the disease may begin in basal stem cells — ...
Scientists have found a way to supercharge lung cancer treatment by transplanting healthy mitochondria into tumors, which both boosts immune response and makes chemotherapy far more effective. By ...
A nanobody-based technology can precisely identify and attack lung cancer cells—sparing surrounding healthy tissue. This is the promise of researchers at the Bio-Nano Research Center at the Korea ...
Squamous cell carcinoma treatment varies by stage, involving surgery, radiation, and systemic therapies based on cancer progression and patient health. Stage 1 focuses on tumor removal, Stage 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results